Bilateral Gradenigo syndrome--on the value of an integrated therapy concept including hyperbaric oxygenation and chronic destructive inflammation of the skull base

What Researchers Did

Researchers presented the case of a 30-year-old woman with bilateral Gradenigo's syndrome to detail the comprehensive treatment approach used.

What They Found

The study emphasized the importance of a complete therapeutic strategy, which included hyperbaric oxygen therapy (HBOT) and specific immunoglobulins as additional treatments. The report discussed the benefits and limitations of these treatment methods in the context of current medical understanding for complex infections.

Canadian Relevance

This study was not conducted in Canada, and the authors are not Canadian. While Gradenigo's syndrome is not a specific Health Canada-recognised indication, the study's focus on complex infection and osteomyelitis of the skull base aligns with refractory osteomyelitis, which is a recognised indication for HBOT in Canada.

Study Limitations

As a case report, this study describes the experience of only one patient, meaning its findings cannot be broadly applied to a larger population.